Mawi
Mawi is a US digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch with AI-powered beat-to-beat rhythm analysis, sold to cardiologists, electrophysiologists, and other healthcare providers through enterprise and direct-to-patient telehealth channels.
- Company typePrivate
- Founded2017
- HeadquartersMiami, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mawi does
Mawi is a US-based digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch for healthcare providers and patients. The patch captures 2-channel ECG data via an X-shaped multiple vector electrode configuration and applies proprietary AI algorithms to perform continuous beat-to-beat analysis, detecting cardiac rhythm abnormalities in real time. The product supports Extended Holter monitoring (up to 7 days; up to 5 days in the US) and Event monitoring today, with Mobile Cardiac Telemetry (MCT) for high-risk patients (up to 30 days of real-time monitoring) listed as 'available soon.' A digital reporting platform delivers technician-validated reports to providers within 24 hours.
The company sells primarily to healthcare providers — cardiologists, electrophysiologists, and other clinicians — via a direct enterprise field sales motion, with role-segmented onboarding (Cardiology/EP, general clinicians, health plan representatives, healthcare executives, technicians). A secondary direct-to-patient telehealth channel enables home self-application, positioning Mawi as a B2B2C device-plus-service offering. Pricing is not publicly disclosed and is handled through quote-based engagement. Revenue mechanics are hardware sales of disposable patches bundled with technician-validated reporting services, billed pay-as-you-go. The company is privately held, incorporated in Delaware (headquartered at 919 North Market Street, Suite 950, Wilmington, DE 19801), operates only in the United States, and has 11-50 employees. Co-founders Ron Fridman (CEO), Andrew Klymenko (President & Chairman), Vitalii Sahan (VP of Engineering), and Artem Malynovskyi (CTO) lead the organization.
Mawi firmographics
Firmographics- Name
- Mawi
- Legal name
- Mawi Inc.
- Website
- https://mawiheart.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mawi is a US digital health company founded in 2017 that develops a single-use, disposable wearable cardiac monitoring patch with AI-powered beat-to-beat rhythm analysis, sold to cardiologists, electrophysiologists, and other healthcare providers through enterprise and direct-to-patient telehealth channels.
- Ownership category
- akta.pro rank
Mawi industry classification
Industry- Product category
- Cardiac Monitoring Devices
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE)
- akta.pro secondary industry
- Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where Mawi is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Mawi business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Revenue model
- Cardiac Monitoring Devices and Services: Mawi generates revenue through the sale of disposable cardiac monitoring patches to healthcare providers and health systems. The monitoring covers extended Holter (up to 7 days, up to 5 days in US), Event monitoring, and Mobile Cardiac Telemetry (MCT) for real-time monitoring up to 30 days. Reports are delivered through a digital platform with certified technician validation.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Extended Holter Monitoring - Low-risk patients |
| Other | Pay-as-you-go | Mobile Cardiac Telemetry (MCT) - High-risk patients |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Mawi product offering
Product offeringCore offering
Mawi designs and sells a single-use, disposable wearable cardiac monitoring patch that captures 2-channel ECG data and uses AI for continuous beat-to-beat rhythm analysis. The offering supports Extended Holter (up to 5-7 days), Event, and Mobile Cardiac Telemetry (up to 30 days) modes, with technician-validated reports delivered through a digital platform within 24 hours. Distribution is B2B to healthcare providers, with a telehealth option that ships the patch directly to patients for self-application at home.
Product overview
Mawi offers a unified cardiac monitoring ecosystem built around a single-use, disposable wearable patch device. The core Mawi Cardiac Monitoring system integrates hardware (wearable ECG patch with 2-channel detection), AI-powered software analysis (beat-to-beat rhythm abnormality detection), and a digital reporting platform. The offering includes multiple monitoring modes: Extended Holter for low-risk patients (up to 5-7 days) and Mobile Cardiac Telemetry for high-risk patients (real-time, up to 30 days). Reports are delivered via a digital platform within 24 hours, validated by certified technicians, and the device supports direct-to-patient telehealth with home self-application.
Differentiator
Problem solved
Functional benefit
Products and services
- Mawi Cardiac Monitoring A wearable cardiac monitoring system consisting of a single-use, fully disposable patch with integrated sensors that captures 2-channel ECG data and uses AI for continuous beat-to-beat analysis to detect cardiac rhythm abnormalities. Sold to healthcare providers for use by patients.
- Extended Holter Monitoring A monitoring configuration of the Mawi patch for low-risk patients, providing continuous cardiac monitoring for up to 7 days (up to 5 days in the US) and capturing ECG data for detailed post-hoc analysis.
- Mobile Cardiac Telemetry (MCT) A real-time monitoring configuration of the Mawi patch for high-risk patients, providing continuous cardiac telemetry for up to 30 days with AI-powered beat-to-beat analysis and technician-validated reports delivered within 24 hours.
- Mawi Digital Platform A digital platform for healthcare providers to access cardiac monitoring reports that are validated by certified technicians and delivered within 24 hours. Enables telehealth capabilities through direct-to-patient shipping and home self-application of the patch.
Quantifiable outcome
- Reports delivered within 24 hours, validated by certified technicians
Companies that use Mawi
Customer profileSegments3 records
Ideal customer profiles2 records
Mawi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Mawi partnerships and signals
Strategic signalScale indicators3 records
Recent moves4 records
Expansion highlights3 records
Mawi competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Medtronic's LINQ family of insertable cardiac monitors (ICMs) and broader cardiac diagnostics franchise competes for long-duration cardiac monitoring prescriptions, particularly in higher-acuity patients.
- GE Healthcare: GE Healthcare offers a portfolio of ambulatory ECG and cardiac telemetry solutions (e.g., MUSE, Holter systems). Broad incumbent in cardiac diagnostics with overlapping clinical customer base but different product mix.
- Bardy Diagnostics (now part of Baxter): Bardy's CAM patch was a notable patch-based cardiac monitor competing in the same extended Holter space. Acquired by Baxter, it represents a now-consolidated competitor in the disposable patch category.
- Preventice Solutions (Boston Scientific): Acquired by Boston Scientific, Preventice offers BodyGuardian remote cardiac monitoring including MCT. Direct overlap in MCT and patch-based cardiac telemetry serving similar cardiology customers.
- Philips (BioTel Heart): Philips acquired BioTel Heart to offer Mobile Cardiac Telemetry, Holter, and Event monitoring services. Overlapping product portfolio in cardiac ambulatory monitoring but as part of a broader health technology portfolio.
Emerging players
- AliveCor: AliveCor offers KardiaMobile, a consumer and clinical ECG device (not patch-based) for arrhythmia detection. Competes for cardiology and primary care cardiac monitoring workflows with a different form factor but similar AI-ECG positioning.
- Biotricity: Biotricity offers Bioflux, a remote cardiac monitoring solution including MCT functionality. Comparable RPM/cardiometabolic monitoring platform competing for similar cardiology and health system accounts.
- HeartBeam: HeartBeam develops a credit-card-sized 3D ECG device for at-home cardiac event detection. Focused on different form factor but similar telehealth-enabled cardiac diagnostic positioning targeting cardiology providers.
- VitalConnect: VitalConnect offers the VitalPatch wearable biosensor for continuous cardiac and multi-parameter monitoring in hospital and remote settings. Comparable wearable + AI monitoring approach with broader vital sign capture.
Direct peers
- iRhythm Technologies: iRhythm's Zio patch is the dominant single-use, long-duration cardiac monitoring patch in the US. Direct competitor offering similar disposable wearable ECG monitoring with AI-assisted analysis for arrhythmia detection.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights7 records
Customer concentration
Mawi social profiles
Digital presenceMawi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mawi leadership team
Management profileNumber of profiles
Profiles4 records
Mawi funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mawi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mawi
What does Mawi do?
Mawi designs and sells a single-use, disposable wearable cardiac monitoring patch that captures 2-channel ECG data and uses AI for continuous beat-to-beat rhythm analysis. The offering supports Extended Holter (up to 5-7 days), Event, and Mobile Cardiac Telemetry (up to 30 days) modes, with technician-validated reports delivered through a digital platform within 24 hours. Distribution is B2B to healthcare providers, with a telehealth option that ships the patch directly to patients for self-application at home.
Is Mawi a public or private company?
Mawi is a private company. It is classified as unknown and is currently operating.
When was Mawi founded?
Mawi was founded in 2017. It employs 11 to 50 people.
Where is Mawi based?
Mawi is headquartered in Miami, United States, in the North America region.
How does Mawi make money?
One revenue line is on record: cardiac Monitoring Devices and Services.
Who are Mawi's main competitors?
Broad incumbents on record are Medtronic, GE Healthcare, Bardy Diagnostics (now part of Baxter), Preventice Solutions (Boston Scientific) and Philips (BioTel Heart). Emerging players are AliveCor, Biotricity, HeartBeam and VitalConnect. iRhythm Technologies is listed as a direct peer.
Does Mawi have an API?
No public API is recorded for Mawi.
What industry is Mawi in?
Mawi's product category is Cardiac Monitoring Devices. Its primary akta.pro industry code is HLAFAKAE, Cardiac Diagnostic Centers (Echo/Stress Testing/Holter), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 6211 and its SIC code is 8011.